-+ 0.00%
-+ 0.00%
-+ 0.00%
Medtech Medical said at the 2026 third quarter results briefing that the company's pharmaceutical equipment is mainly customized non-standard equipment. The company is continuing to develop customers in the direction of biopharmaceuticals, medical aesthetics, weight reduction injection pens, and pre-encapsulation. Existing customers have entered into business, and in the end, the formal contract signed between the two parties shall prevail. At the same time, the company is actively promoting an international layout, continuing to explore the needs of overseas consumables manufacturers, and steadily expanding overseas markets.
Share
Listen to the news
Medtech Medical said at the 2026 third quarter results briefing that the company's pharmaceutical equipment is mainly customized non-standard equipment. The company is continuing to develop customers in the direction of biopharmaceuticals, medical aesthetics, weight reduction injection pens, and pre-encapsulation. Existing customers have entered into business, and in the end, the formal contract signed between the two parties shall prevail. At the same time, the company is actively promoting an international layout, continuing to explore the needs of overseas consumables manufacturers, and steadily expanding overseas markets.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending